Jane Street
LGND icon

Jane Street’s Ligand Pharmaceuticals LGND Stock Holding History

Jane Street’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
4,000
+1,900
+90% +$448K ﹤0.01% 6041
2026
Q1 		$419K Buy
+2,100
New +$415K ﹤0.01% 8461
2025
Q4 		– Sell
-9,600
Closed -$1.7M – 11838
2025
Q3 		$1.7M Buy
+9,600
New +$1.43M ﹤0.01% 5241
2022
Q1 		– Sell
-3,527
Closed -$340K – 10708
2021
Q4 		$340K Sell
3,527
-3,847
-52% -$355K ﹤0.01% 7941
2021
Q3 		$641K Buy
7,374
+962
+15% +$74.4K ﹤0.01% 6807
2021
Q2 		$525K Sell
6,412
-467,275
-99% -$38.9M ﹤0.01% 7142
2021
Q1 		$45M Buy
473,687
+436,978
+1,190% +$41.3M 0.02% 530
2020
Q4 		$2.28M Sell
36,709
-40,235
-52% -$2.29M ﹤0.01% 3264
2020
Q3 		$4.58M Sell
76,944
-98,424
-56% -$6.72M ﹤0.01% 1946
2020
Q2 		$12.2M Buy
175,368
+157,575
+886% +$9.99M 0.01% 1048
2020
Q1 		$807K Buy
+17,793
New +$1.01M ﹤0.01% 3046
2019
Q1 		– Sell
-10,900
Closed -$923K – 5365
2018
Q4 		$923K Buy
+10,900
New +$1.16M ﹤0.01% 2683
2017
Q2 		– Sell
-100,188
Closed -$6.62M – 4652
2017
Q1 		$6.62M Buy
+100,188
New +$6.59M 0.03% 550
2016
Q2 		– Sell
-6,412
Closed -$428K – 4350
2016
Q1 		$428K Buy
+6,412
New +$390K ﹤0.01% 2772

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's LGND Position: Q2 2026 in Review

Jane Street sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 12,906 shares — an estimated $3.04M sold.

Jane Street first reported a position in LGND in Q2 2013 and held it in 35 quarters. The position peaked at $9.19M in Q3 2025. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Jane Street reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 12,906 Ligand Pharmaceuticals shares in Q2 2026, an estimated $3.04M.
  • Jane Street first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 35 quarters.
  • Jane Street's Ligand Pharmaceuticals position peaked at $9.19M in Q3 2025.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.